IGC Pharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell IGC Pharma and other ETFs, options, and stocks.About IGC
IGC Pharma, Inc. is a clinical-stage pharmaceutical company that is focused on Alzheimer's disease, developing innovative solutions to address this devastating illness. It has two investigational drug assets targeting Alzheimer's disease: IGC-AD1, which is in a Phase 2 clinical trial as a treatment for agitation in dementia due to Alzheimer's and TGR-63 that is in pre-clinical development.
CEORam Mukunda
CEORam Mukunda
Employees70
Employees70
HeadquartersPotomac, Maryland
HeadquartersPotomac, Maryland
Founded2005
Founded2005
Employees70
Employees70
IGC Key Statistics
Market cap28.92M
Market cap28.92M
Price-Earnings ratio-3.87
Price-Earnings ratio-3.87
Dividend yield—
Dividend yield—
Average volume417.53K
Average volume417.53K
High today$0.3043
High today$0.3043
Low today$0.2801
Low today$0.2801
Open price$0.296
Open price$0.296
Volume814.49K
Volume814.49K
52 Week high$0.4985
52 Week high$0.4985
52 Week low$0.2525
52 Week low$0.2525
Stock Snapshot
With a market cap of 28.92M, IGC Pharma(IGC) trades at $0.30. The stock has a price-to-earnings ratio of -3.87.
During the trading session on 2026-01-22, IGC Pharma(IGC) shares reached a daily high of $0.30 and a low of $0.28. At a current price of $0.30, the stock is +8.4% higher than the low and still -0.2% under the high.
Trading volume for IGC Pharma(IGC) stock has reached 814.49K, versus its average volume of 417.53K.
The stock's 52-week range extends from a low of $0.25 to a high of $0.50.
The stock's 52-week range extends from a low of $0.25 to a high of $0.50.
IGC News
TipRanks 14h
IGC Pharma expands Phase 2 CALMA trial with new clinical siteIGC Pharma (IGC) announced the addition of Integrative Clinical Trials, located in Brooklyn, New York, as a new clinical site participating in the Company’s Pha...
People also own
Based on the portfolios of people who own IGC. This list is generated using Robinhood data, and it’s not a recommendation.